Lentigen Corporation
, is a privately held biotechnology company focused on the development of lentiviral vectors using its proprietary gene delivery technology for a wide range of applications in biotechnology and medicine. Lentiviral vectors are highly adapted delivery vehicles that can transport genes or gene silencing sequences into cells with high efficiency and stability.
Read More
http://www.lentigen.com
HyperMed, Inc.
is the leader in non-invasive Hyperspectral medical imaging. Their first diagnostic product, OXyVu-1, received diagnostic clearance in November, 2006 for use in assessing patients for poor tissue circulation including those with diabetic foot ulcers, leg pain or other symptoms of poor blood flow.
Read More
http://www.hypermed-inc.com
Spectral Image, Inc.
is a privately held, early stage medical device company focused on the development of imaging technology for biomedical use. The company is currently in stealth mode.
Read More
GBP IP, LLC is the privately held intellectual property affiliate of GBP Capital.
Read More
Flexible Stenting Solutions, Inc. is a privately held medical device company focused on the development and commercialization of flexible stents built on a proprietary design platform.
Read More
MabVax Therapeutics, Inc. is a
privately held immunotherapeutics discovery and development company focused on the development and commercialization of novel immunotherapies for the treatment of cancer.
TMune Therapeutics is a venture stage biotechnology company focused on the development of T cell therapies for the treatment of cancer and infectious disease.
The company’s proprietary T cell activation technology has been safely administered in more than 400 patients and has shown promise in the treatment in leukemia, lymphoma and HIV, which are planned to enter into Phase II clinical trials.
|
